Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 TrialWilliam Greenhalf, Markus W. Büchler, John P. Neoptolemos et al.|JNCI Journal of the National Cancer Institute|2013Cited by 333
A MAP4 kinase related to <i>Ste20</i> is a nutrient-sensitive regulator of mTOR signallingGreg M. Findlay, Richard F. Lamb|Biochemical Journal|2007Cited by 255
Hyperactivation of Mammalian Target of Rapamycin (mTOR) Signaling by a Gain-of-Function Mutant of the Rheb GTPaseLijun Yan, Richard F. Lamb|Journal of Biological Chemistry|2006Cited by 73